Skin delivery and in vitro biological evaluation of trans-Resveratrol-Loaded solid lipid nanoparticles for skin disorder therapies

Molecules

Volumn 21, Issue 1, 2016, Pages

  Rigon, Roberta B ^a   Fachinetti, Naiara ^a   Severino, Patrícia ^b   Santana, Maria H A ^c   Chorilli, Marlus ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b TIRADENTES UNIVERSITY   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Drug delivery system; Permeation; Skin disorders; Solid lipid nanoparticle; Trans resveratrol; Tyrosinase

Indexed keywords

DRUG CARRIER; LIPID; NANOPARTICLE; RESVERATROL; STILBENE DERIVATIVE;

CELL LINE; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; HUMAN; MEDICINAL CHEMISTRY; METABOLISM; PARTICLE SIZE; PATHOLOGY; PERMEABILITY; SKIN; SKIN DISEASES; ULTRASTRUCTURE;

CALORIMETRY, DIFFERENTIAL SCANNING; CELL LINE; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LIPIDS; NANOPARTICLES; PARTICLE SIZE; PERMEABILITY; SKIN; SKIN DISEASES; STILBENES;

EID: 85000843972     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21010116     Document Type: Article

References (64)

1. Ndiaye, M.; Philippe, C.; Mukhtar, H.; Ahmad, N. The grape antioxidant resveratrol for skin disorders: Promise, prospects, and challenges. Arch. Biochem. Biophys. 2011, 508, 164-170. [CrossRef] [PubMed].
2. Fagundo, E.; Rodríguez-García, C.; Rodríguez, C.; González, S.; Sánchez, R.; Jiménez, A. Analysis of phenotypic characteristics and exposure to UV radiation in a group of patients with cutaneous melanoma. Actas Dermo Sifiliogr. 2011, 102, 599-604. [CrossRef] [PubMed].
3. Bay, C.; Kejs, A.M.T.; Storm, H.H.; Engholm, G. Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: A danish population-based register study 1989-2011. Cancer Epidemiol. 2014, 39, 1-7. [CrossRef] [PubMed].
4. Rigon, R.B.; Oyafuso, M.H.; Fujimura, A.T.; Gonçalez, M.L.; do Prado, A.H.; Gremião, M.P.D.; Chorilli, M. Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review. Biomed. Res. Int. 2015, 2015, 1-22. [CrossRef] [PubMed].
5. De Souza, G.A.; Godoy, L.M.; Teixeira, V.R.; Otake, A.H.; Sabino, A.; Rosa, J.C.; Dinarte, A.R.; Pinheiro, D.G.; Silva, W.A.; Eberlin, M.N. Proteomic and SAGE profiling of murine melanoma progression indicates the reduction of proteins responsible for ROS degradation. Proteomics 2006, 6, 1460-1470. [CrossRef] [PubMed].
6. Slominski, A.; Paus, R.; Mihm, M. Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: Selective review and hypothesis. Anticancer Res. 1997, 18, 3709-3715.
7. Slominski, A.;Wortsman, J.; Carlson, A.J.; Matsuoka, L.Y.; Balch, C.M.; Mihm, M.C. Malignant melanoma. Arch. Pathol. Lab. Med. 2001, 125, 1295-1306. [PubMed].
8. Slominski, A.; Zbytek, B.; Slominski, R. Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells. Int. J. Cancer 2009, 124, 1470-1477. [CrossRef] [PubMed].
9. Sohn, N.; Gumport, S.L.; Gang, H.; Goldstein, M.; Deppisch, L.M. Generalized melanosis secondary to malignant melanoma. Report of a case with serum and tissue tyrosinase studies. Cancer 1969, 24, 897-903. [CrossRef].
10. Gehm, B.D.; McAndrews, J.M.; Chien, P.Y.; Jameson, J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA 1997, 94, 14138-14143. [CrossRef] [PubMed].
11. Shukla, Y.; Singh, R. Resveratrol and cellular mechanisms of cancer prevention. Ann. N. Y. Acad. Sci. 2011, 1215, 1-8. [CrossRef] [PubMed].
12. Kim, A.; Yang, Y.; Lee, M.S.; Yoo, Y.D.; Lee, H.G.; Lim, J.S. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression. Pigment Cell Melanoma Res. 2008, 21, 653-664. [CrossRef] [PubMed].
13. Santos, F.K.; Oyafuso, M.H.; Kiill, C.P.; Gremião, M.P.D.; Chorilli, M. Nanotechnology-based drug delivery systems for treatment of hyperproliferative skin diseases-A review. Curr. Nanosci. 2013, 9, 159-167.
14. Souza, A.L.R.; Kiill, C.P.; Santos, F.K.; Luz, G.M.; Chorilli, M.; Gremião, M.P.D. Nanotechnology-based drug delivery systems for dermatomycosis treatment. Curr. Nanosci. 2012, 8, 512-519. [CrossRef].
15. Liu, J.; Hu, W.; Chen, H.; Ni, Q.; Xu, H.; Yang, X. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm. 2007, 328, 191-195. [CrossRef] [PubMed].
16. Wong, H.L.; Bendayan, R.; Rauth, A.M.; Li, Y.; Wu, X.Y. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv. Drug Deliver. Rev. 2007, 59, 491-504. [CrossRef] [PubMed].
17. Noguchi, Y.; Wu, J.; Duncan, R.; Strohalm, J.; Ulbrich, K.; Akaike, T.; Maeda, H. Early phase tumor accumulation of macromolecules: A great difference in clearance rate between tumor and normal tissues. Jpn. J. Cancer Res. 1998, 89, 307-314. [CrossRef] [PubMed].
18. Iyer, A.K.; Khaled, G.; Fang, J.; Maeda, H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov. Today 2006, 11, 812-818. [CrossRef] [PubMed].
19. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J. Control. Release 2000, 65, 271-284. [CrossRef].
20. Lim, S.J.; Lee, M.K.; Kim, C.K. Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. J. Control. Release 2004, 100, 53-61. [CrossRef] [PubMed].
21. Mehnert, W.; Mäder, K. Solid lipid nanoparticles: Production, characterization and applications. Adv. Drug Deliver. Rev. 2001, 47, 165-196. [CrossRef].
22. Lira, A.; Araújo, A.; Basílio, I.; Santos, B.; Santana, D.; Macedo, R. Compatibility studies of lapachol with pharmaceutical excipients for the development of topical formulations. Thermochim. Acta 2007, 457, 1-6. [CrossRef].
23. Hawkins, G.S.; Reifenrath, W.G. Influence of skin source, penetration cell fluid, and, partition coefficient on in vitro skin penetration. J. Pharm. Sci. 1986, 75, 378-381. [CrossRef] [PubMed].
24. Wagner, H.; Kostka, K.H.; Lehr, C.M.; Schaefer, U.F. Interrelation of permeation and penetration parameters obtained from in vitro experiments with human skin and skin equivalents. J. Control. Release 2001, 75, 283-295. [CrossRef].
25. Dick, I.P.; Scott, R.C. Pig ear skin as an in vitro model for human skin permeability. J. Pharm. Pharmacol. 1992, 44, 640-645. [CrossRef] [PubMed].
26. Sandoval, B. Tratamiento del melasma con ácido kójico. Folia Dermatol. Peru 1999, 10, 53-56.
27. Benavides, T.; Martinez, V.; Mitjans, M.; Infante, M.A.R.; Moran, C.; Clapés, P.; Clothier, R.; Vinardell, M.A.P. Assessment of the potential irritation and photoirritation of novel amino acid-based surfactants by in vitro methods as alternative to the animal tests. Toxicology 2004, 201, 87-93. [CrossRef] [PubMed].
28. Kyadarkunte, A.; Patole, M.; Pokharkar, V. In Vitro Cytotoxicity and Phototoxicity Assessment of Acylglutamate Surfactants Using a Human Keratinocyte Cell Line. Cosmetics 2014, 1, 159-170. [CrossRef].
29. Schaefer, H.;Watts, F.; Brod, J.; Illel, B. Follicular penetration. In Prediction of Percutaneous Penetration: Methods, Measurements and Modeling; IBC Technical Services: London, UK, 1990; pp. 163-173.
30. Küchler, S.; Abdel-Mottaleb, M.; Lamprecht, A.; Radowski, M.R.; Haag, R.; Schäfer-Korting, M. Influence of nanocarrier type and size on skin delivery of hydrophilic agents. Int. J. Pharm. 2009, 377, 169-172. [CrossRef] [PubMed].
31. Shim, J.; Kang, H.S.; Park, W.S.; Han, S.H.; Kim, J.; Chang, I.S. Transdermal delivery of mixnoxidil with block copolymer nanoparticles. J. Control. Release 2004, 97, 477-484. [CrossRef].
32. De Vringer, T.; de Ronde, H. Preparation and structure of a water-in-oil cream containing lipid nanoparticles. J. Pharm. Sci. 1995, 84, 466-472. [CrossRef] [PubMed].
33. Lee, A.; Tojo, K. Characterization of skin permeation of vitamin C: Theoretical analysis of penetration profiles and differential scanning calorimetry study. Chem. Pharm. Bull. 1998, 46, 174-177. [CrossRef] [PubMed].
34. Nidhin, M.; Indumathy, R.; Sreeram, K.; Nair, B.U. Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templates. Bull. Mater. Sci. 2008, 31, 93-96. [CrossRef].
35. Krause, B.; Mende, M.; Pötschke, P.; Petzold, G. Dispersability and particle size distribution of CNTs in an aqueous surfactant dispersion as a function of ultrasonic treatment time. Carbon 2010, 48, 2746-2754. [CrossRef].
36. Schwarz, C.; Mehnert, W.; Lucks, J.; Müller, R. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J. Control. Release 1994, 30, 83-96. [CrossRef].
37. Akhtar, N.; Pathak, K. Cavamax w7 composite ethosomal gel of clotrimazole for improved topical delivery: development and comparison with ethosomal gel. AAPS PharmSciTech 2012, 13, 344-355. [CrossRef] [PubMed].
38. Zhang, H.; Tehrany, E.A.; Kahn, C.; Ponçot, M.; Linder, M.; Cleymand, F. Effects of nanoliposomes based on soya, rapeseed and fish lecithins on chitosan thin films designed for tissue engineering. Carbohydr. Polym. 2012, 88, 618-627. [CrossRef].
39. Freitas, C.; Müller, R.H. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. Int. J. Pharm. 1998, 168, 221-229. [CrossRef].
40. Lourenco, C.; Teixeira, M.; Simões, S.; Gaspar, R. Steric stabilization of nanoparticles: Size and surface properties. Int. J. Pharm. 1996, 138, 1-12. [CrossRef].
41. Dubes, A.; Parrot-Lopez, H.; Abdelwahed, W.; Degobert, G.; Fessi, H.; Shahgaldian, P.; Coleman, A.W. Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. Eur. J. Pharm. Biopharm. 2003, 55, 279-282. [CrossRef].
42. Cides, L.C.; Araújo, A.A.; Santos-Filho, M.; Matos, J. Thermal behaviour, compatibility study and decomposition kinetics of glimepiride under isothermal and non-isothermal conditions. J. Therm. Anal. Calorim. 2006, 84, 441-445. [CrossRef].
43. Nepal, P.R.; Han, H.K.; Choi, H.K. Enhancement of solubility and dissolution of Coenzyme Q10 using solid dispersion formulation. Int. J. Pharm. 2010, 383, 147-153. [CrossRef] [PubMed].
44. Lira, A.A.; Nanclares, D.M.; Neto, A.F.; Marchetti, J. Drug-polymer interaction in the all-trans retinoic acid release from chitosan microparticles. J. Therm. Anal. Calorim. 2007, 87, 899-903. [CrossRef].
45. Rudyanto, M.; Ihara, M.; Takasu, K.; Yoshida, M.; Poerwono, H.; Sudiana, I.K.; Indrayanto, G.; Brittain, H.G. Propylparaben: Physical Characteristics. Profiles Drug Subst. Excip. Relat. Methodol. 2003, 30, 235-269. [PubMed].
46. Newa, M.; Bhandari, K.H.; Li, D.X.; Kwon, T.H.; Kim, J.A.; Yoo, B.K.; Woo, J.S.; Lyoo, W.S.; Yong, C.S.; Choi, H.G. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int. J. Pharm. 2007, 343, 228-237. [CrossRef] [PubMed].
47. Bikiaris, D.; Papageorgiou, G.Z.; Stergiou, A.; Pavlidou, E.; Karavas, E.; Kanaze, F.; Georgarakis, M. Physicochemical studies on solid dispersions of poorly water soluble drugs: Evaluation of capabilities and limitations of thermal analysis techniques. Thermochim. Acta 2005, 439, 58-67. [CrossRef].
48. Bonina, F.; Montenegro, L.; Scrofani, N.; Esposito, E.; Cortesi, R.; Menegatti, E.; Nastruzzi, C. Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate. J. Control. Release 1995, 34, 53-63. [CrossRef].
49. Yokomizo, Y.; Sagitani, H. The effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pig in vitro. 2. The effects of the hydrophobic group in phospholipids and a comparison with general enhancers. J. Control. Release 1996, 42, 37-46. [CrossRef].
50. Dreher, F.; Walde, P.; Walther, P.;Wehrli, E. Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J. Control. Release 1997, 45, 131-140. [CrossRef].
51. Ferderber, K.; Hook, S.; Rades, T. Phosphatidyl choline-based colloidal systems for dermal and transdermal drug delivery. J. Liposome Res. 2009, 19, 267-277. [CrossRef] [PubMed].
52. Bentley, M.V.L.; Kedor, E.R.; Vianna, R.F.; Collett, J.H. The influence of lecithin and urea on the in vitro permeation of hydrocortisone acetate through skin from hairless mouse. Int. J. Pharm. 1997, 146, 255-262. [CrossRef].
53. Bentley, M.V.L.; Marchetti, J.M.; Ricardo, N.; Ali-Abi, Z.; Collett, J.H. Influence of lecithin on some physical chemical properties of poloxamer gels: Rheological, microscopic and in vitro permeation studies. Int. J. Pharm. 1999, 193, 49-55. [CrossRef].
54. Kirjavainen, M.; Urtti, A.; Valjakka-Koskela, R.; Kiesvaara, J.; Mönkkönen, J. Liposome skin interactions and their effects on the skin permeation of drugs. Eur. J. Pharm. Sci. 1999, 7, 279-286. [CrossRef].
55. Escobar-Chavez, J.J.; Merino-Sanjuán, V.; López-Cervantes, M.; Urban-Morlan, Z.; Pinon-Segundo, E.; Quintanar-Guerrero, D.; Ganem-Quintanar, A. The tape-stripping technique as a method for drug quantification in skin. J. Pharm. Pharm. Sci. 2008, 11, 104-130. [PubMed].
56. Herkenne, C.; Alberti, I.; Naik, A.; Kalia, Y.N.; Mathy, F.X.; Préat, V.; Guy, R.H. In vivo methods for the assessment of topical drug bioavailability. Pharm. Res. 2008, 25, 87-103. [CrossRef] [PubMed].
57. Shubar, H.M.; Mayer, J.P.; Hopfenmüller, W.; Liesenfeld, O. A new combined flow-cytometry-based assay reveals excellent activity against Toxoplasma gondii and low toxicity of new bisphosphonates in vitro and in vivo. J. Antimicrob. Chemother. 2008, 61, 1110-1119. [CrossRef] [PubMed].
58. Agayan, R.R.; Horvath, T.; McNaughton, B.H.; Anker, J.N.; Kopelman, R. Optical manipulation of metal-silica hybrid nanoparticles. In Optical Science and Technology, Proceedings of the SPIE 49th Annual Meeting, International Society for Optics and Photonics, Denver, CO, USA, 6 August 2004; University of Michigan: Ann Arbor, MI, USA, 2004; pp. 502-513.
59. Primo, F.L.; Bentley, M.V.; Tedesco, A.C. Photophysical studies and in vitro skin permeation/retention of Foscan®/nanoemulsion (NE) applicable to photodynamic therapy skin cancer treatment. J. Nanosci. Nanotechnol. 2008, 8, 340-347. [PubMed].
60. Gonçalez, M.; Corrêa, M.; Chorilli, M. Skin delivery of kojic acid-loaded nanotechnology-based drug delivery systems for the treatment of skin aging. Biomed. Res. Int. 2013, 2013. [CrossRef] [PubMed].
61. Kobayashi, Y.; Kayahara, H.; Tadasa, K.; Nakamura, T.; Tanaka, H. Synthesis of amino acid derivates of kojic acid and their tyrosinase inhibitory activity. Biosci. Biotechnol. Biochem. 1995, 59, 1745-1746. [CrossRef].
62. Oliveira, M.B.; do Prado, A.H.; Bernegossi, J.; Sato, C.S.; Lourenço Brunetti, I.; Scarpa, M.V.; Leonardi, G.R.; Friberg, S.E.; Chorilli, M. Topical Application of Retinyl Palmitate-Loaded Nanotechnology-Based Drug Delivery Systems for the Treatment of Skin Aging. Biomed. Res. Int. 2014, 2014. [CrossRef] [PubMed].
63. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63. [CrossRef].
64. Alvarez-Román, R.; Naik, A.; Kalia, Y.; Guy, R.H.; Fessi, H. Skin penetration and distribution of polymeric nanoparticles. J. Control. Release 2004, 99, 53-62. [CrossRef] [PubMed].